Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drug

Humira(Cf)(Adalimumab)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$400.9M

Medicare cost, 2024

Medicare drug plans spent $400.9 million on Humira(Cf) (adalimumab) in 2024, for 46,620 prescriptions and refills filled by 6,661 patients. At about $8,599 per prescription it is a high-cost drug. Texas accounts for the most spending ($31.8 million, 8% of the total).

Medicare cost, 2024

$400.9M

-10.1% from 2023

Prescriptions

47K

$8,599.32 per claim

Patients

6,661

5,384 prescribers

Total spending, 2024

$400.9M

$60,186.23 per patient

Questions and answers

How much does Medicare spend on Humira(Cf)?

Medicare prescription drug plans paid $400.9M for Humira(Cf) in 2024, for 46,620 prescriptions and refills to 6,661 patients (down 10.1% from 2023). The average cost per claim was $8,599.32.

Which state spends the most on Humira(Cf)?

Texas had the highest Medicare cost for Humira(Cf) in 2024: $31.8M for 3,552 claims, followed by New York ($30.9M).

Who prescribes Humira(Cf) the most?

Michael Babilonia Roman, internal medicine in Mayaguez, PR, had the highest Medicare cost for Humira(Cf) in 2024: 265 claims costing $1.8M.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Humira(Cf) was $400.9M in 2024, after a high of $445.8M in 2023.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Humira(Cf), 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Michael Babilonia Roman Mayaguez, PRInternal Medicine26528$1.8M
Elvin R Garcia McAllen, TXRheumatology19425$1.4M
Roger R Wang San Francisco, CAAllergy/ Immunology21225$1.3M
Ya Ju Chang New York, NYRheumatology17620$1.2M
Carl Restivo Jr. Jersey City, NJRheumatology14915$1.1M
Roberto D Alvarez Aibonito, PRRheumatology14820$1.0M
Ravi Bhalla Peoria, AZRheumatology9312$895K
Jonathan Rene Saginaw, MIRheumatology79Under 11$707K
Allan A Ramey Lancaster, MARheumatology89Under 11$671K
Bradley Toews Tulsa, OKPhysician Assistant68Under 11$664K
Thomas E Lafferty Ocala, FLRheumatology69Under 11$657K
Yong H Tsai Daytona Beach, FLRheumatology8911$656K
Osvaldo Antommattei Ponce, PRRheumatology9711$650K
Anthony M Kahr Bend, ORRheumatology89Under 11$624K
Preethi Thomas Radnor, PARheumatology50Under 11$621K
Grace A Makhlouf Sugar Land, TXRheumatology36Under 11$617K
Monika Mohan Okemos, MIRheumatology8011$566K
Shirley A Albano Hershey, PARheumatology68Under 11$534K
James E Dowd Brighton, MIRheumatology68Under 11$521K
Roy C Sampson Lowell, ARRheumatology74Under 11$503K
Stephannie L Legarretta Horizon City, TXNurse Practitioner54Under 11$490K
Susan M Goodman New York, NYRheumatology61Under 11$488K
Kenneth B Wiesner Sacramento, CARheumatology44Under 11$485K
Marta T Bognar Gainesville, GARheumatology67Under 11$484K
Zaida Z Fuxench Lopez Bayamon, PRInternal Medicine33Under 11$456K

Prescriber data by year

YearPrescribersClaimsPatientsCost
20225,41549,5647,125$410.2M
20235,55149,8227,028$445.7M
20245,38446,6206,661$400.9M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Abbvie US LLCABBV logoABBV43,590$372.6M
Cordavis LimiteCVS logoCVS3,030$28.3M

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube